Journal
HUMAN MOLECULAR GENETICS
Volume 22, Issue 4, Pages 825-831Publisher
OXFORD UNIV PRESS
DOI: 10.1093/hmg/dds489
Keywords
-
Funding
- MRC
- Cancer Research UK
- Bayer
- Cancer Research UK [C1298/A8362, C490/A10124]
- Bobby Moore Fund
- Leukaemia Lymphoma Research
- NHS
- Intramural Research Program of the National Cancer Institute, NIH
- Cancer Research UK [6858] Funding Source: researchfish
- Medical Research Council [MC_UU_12023/4, MC_U122861326] Funding Source: researchfish
- MRC [MC_UU_12023/4, MC_U122861326] Funding Source: UKRI
Ask authors/readers for more resources
Genome-wide association studies (GWASs) of renal cell cancer (RCC) have identified four susceptibility loci thus far. To identify an additional RCC common susceptibility locus, we conducted a GWAS and performed a meta-analysis with published GWASs (totalling 2215 cases and 8566 controls of European background) and followed up the most significant association signals [nine single nucleotide polymorphisms (SNPs) in eight genomic regions] in 3739 cases and 8786 controls. A combined analysis identified a novel susceptibility locus mapping to 2q22.3 marked by rs12105918 (P 1.80 10(8); odds ratio 1.29, 95 CI: 1.181.41). The signal localizes to intron 2 of the ZEB2 gene (zinc finger E box-binding homeobox 2). Our findings suggest that genetic variation in ZEB2 influences the risk of RCC. This finding provides further insights into the genetic and biological basis of inherited genetic susceptibility to RCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available